Devising two-stage and multistage phase II studies on systemic adjuvant therapy for uveal melanoma. (2012)
Attributed to:
North West HTMR
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1167/iovs.12-9858
PubMed Identifier: 22743326
Publication URI: http://europepmc.org/abstract/MED/22743326
Type: Journal Article/Review
Volume: 53
Parent Publication: Investigative ophthalmology & visual science
Issue: 8
ISSN: 0146-0404